KANSAS CITY, Mo. — Nov. 6, 2007 — Cerner Corp. (NASDAQ: CERN) today announced a nine-year agreement for the United States Department of Veterans Affairs (VA) to utilize Cerner Millennium® PathNet® laboratory information system in more than 150 hospitals and 800 clinics in the Veterans Health Administration system.

"Looking to increase patient safety in its clinical laboratories, the VA has made the decision to use the Cerner PathNet solution, embracing the new technology also chosen by the Department of Defense for its laboratories," said Mike Valentine, Cerner executive vice president. "This coordinated strategy will help both agencies to better serve all U.S. veterans."

The Millennium PathNet laboratory information system is a comprehensive, integrated technology that automates both the clinical and managerial sides of the laboratory, and it is the only system of its kind to do so. Patient safety increases when specimens are quickly processed, tested and classified. Faster answers mean faster decisions for doctors, nurses and families. The suite of PathNet solutions tracks specimens from collection through testing and storage, and it helps unify workflow through bar codes, robotics and instrument interfaces. In addition to streamlining workflow in the laboratory, PathNet can reduce turnaround times through automatic verification and reporting. The system simplifies the process of entering results, tracking repeat entries and corrections.

This will be the largest implementation of PathNet to date for Cerner. Coupled with the Department of Defense, another Cerner client, these federal implementations represent approximately five percent of all U.S. hospitals. Additionally, this implementation means that clinical laboratories for all service members, past and present, will be operating on the same laboratory information software.

"Like the rest of the healthcare industry, the VA is modernizing and expanding its informatics infrastructure. Cerner’s proven laboratory solution is a core component of that objective," said Gary Dickerson, Cerner’s director of federal programs. "Cerner is proud to work together with the VA to serve our nation’s veterans. It is our distinct honor to be able to provide technology that helps to deliver the healthcare and recovery of our servicemen and women."

The VA will install a broad set of PathNet laboratory solutions during the three-phase implementation program in an effort to streamline complex workflows, help eliminate errors and improve the quality and performance of laboratories. Additionally, the VA will employ Cerner’s Millennium Helix™ solution for molecular testing, a Human Leukocyte Antigen module for testing tissue compatibility, and robotic interfaces in its more advanced clinical laboratory settings.

About Cerner

Cerner Corp. is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 6,000 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner, Cerner Millennium, PathNet, Millennium Helix, Cerner’s logo. NASDAQ: CERN. www.cerner.com.

This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "can" and "will" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subjected to infringement claims or may be infringed upon; risks related to our reliance on third party suppliers; government regulation; and, failure of the parties to achieve the intended benefits. Additional discussion of these and other factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.